MedPath

DexMoxiKetor PF

Approved
Approval ID

6bb7c6fb-ac41-764c-e053-2991aa0a3b60

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 8, 2018

Manufacturers
FDA

ImprimisRx NJ

DUNS: 931390178

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dexamethasone - Moxifloxacin - Ketorolac PF

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70261-513
Product Classification
G
Generic Name
Dexamethasone - Moxifloxacin - Ketorolac PF
Product Specifications
Route of AdministrationINTRAOCULAR
Effective DateMay 8, 2018
FDA Product Classification

INGREDIENTS (3)

DEXAMETHASONE SODIUM PHOSPHATEActive
Quantity: 1 mg in 1 mL
Code: AI9376Y64P
Classification: ACTIR
KETOROLAC TROMETHAMINEActive
Quantity: 0.4 mg in 1 mL
Code: 4EVE5946BQ
Classification: ACTIM
MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATEActive
Quantity: 0.5 mg in 1 mL
Code: B8956S8609
Classification: ACTIM

Drug Labeling Information

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 1/1/2018

Store at 20° to 25° C (68° to 77° F)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.